The distributor reported the event on behalf of the customer.The customer alleged receiving a (b)(6) result using a (b)(6) dipstick test.Per the customer, a digital clock was used for the test instead of a timer.No information on confirmatory testing was provided.Although requested, no additional information was provided.
|
Investigation conclusion: retention and returned products were tested with hcg quality control cut-off standard (25miu/ml) and high level hcg clinical urine (212.6iu/ml, 215.2iu/ml, 203.5iu/ml).All devices showed positive results at read time and met quality control specifications.No false negative results were obtained during in-house testing.Manufacturing batch records of the final-product, relevant product components, and quality control release data were reviewed.No relevant non-conformance, deviations, or abnormalities were found.All quality control specifications were met.Retention and returned products performed as expected during in-house testing and could not replicate the reported complaint.This issue will be subject to tracking and trending.Case details do not indicate if the urine sample was a first morning catch.Per the package insert, very dilute urine may not contain representative levels of hcg.This test provides a presumptive diagnosis for pregnancy.A confirmed pregnancy diagnosis should only be made by a physician after all clinical and laboratory findings have been evaluated.Based on the information available, there is no indication of a product deficiency and no corrective action is required.(additional device information) updated to include unique device identifier (b)(4).
|